🇺🇸 FDA
Patent

US 10952993

Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

granted A61KA61K31/426A61K38/28

Quick answer

US patent 10952993 (Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs) held by VTV THERAPEUTICS LLC expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VTV THERAPEUTICS LLC
Grant date
Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/426, A61K38/28, A61K45/06, A61K9/0053